Investors Ready for Brain Cancer Biotech Tocagen's Upcoming IPO This Wednesday
Tocagen Inc. (Pending:TOCA) expects to raise $70 million in its upcoming IPO ($81.5 million, if the underwriters exercise their option to purchase additional shares).
Based in San Diego, California, Tocagen is a clinical-stage company that is developing gene therapies to activate a patient's immune system against cancer.
We previewed this deal on our IPO Insights platform.
Based in San Diego, California, Tocagen is a clinical-stage company that is developing gene therapies to activate a patient's immune system against cancer.
We previewed this deal on our IPO Insights platform.